Nationwide Fund Advisors - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 143 filers reported holding CLOVIS ONCOLOGY INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2017$13,345,000
+21.4%
161,958
+37.9%
0.05%
+18.2%
Q2 2017$10,995,000
+302.7%
117,428
+173.9%
0.04%
+300.0%
Q1 2017$2,730,000
+60.1%
42,870
+11.7%
0.01%
+57.1%
Q4 2016$1,705,000
+129.5%
38,385
+86.1%
0.01%
+133.3%
Q3 2016$743,000
+162.5%
20,6230.0%0.00%
+200.0%
Q2 2016$283,000
-17.5%
20,623
+15.4%
0.00%0.0%
Q1 2016$343,000
-46.7%
17,869
-2.8%
0.00%
-66.7%
Q4 2015$644,000
-93.0%
18,393
-81.6%
0.00%
-92.7%
Q3 2015$9,213,000
+550.2%
100,189
+521.3%
0.04%
+583.3%
Q2 2015$1,417,000
-44.2%
16,126
-52.9%
0.01%
-40.0%
Q1 2015$2,541,000
+118.7%
34,226
+65.0%
0.01%
+100.0%
Q4 2014$1,162,000
+22.1%
20,743
-1.2%
0.01%
+25.0%
Q3 2014$952,000
+9.7%
20,998
+0.1%
0.00%0.0%
Q2 2014$868,000
-18.3%
20,973
+36.7%
0.00%
-20.0%
Q1 2014$1,062,000
+27.2%
15,337
+10.7%
0.01%
+66.7%
Q4 2013$835,000
+8.2%
13,858
+9.1%
0.00%0.0%
Q3 2013$772,000
+10.4%
12,704
+21.7%
0.00%
-25.0%
Q2 2013$699,00010,4400.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2014
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders